666

YABAO PHARMACEUTICAL GROUP

No trades
See on Supercharts

600351 fundamentals

YABAO PHARMACEUTICAL GROUP financial statements, including revenue, expenses, profit, and loss

The total revenue of 600351 for the last quarter is 761.16 M CNY, and it's 8.30% higher compared to the previous quarter. The net income of Q1 24 is 112.26 M CNY.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth